Anıl Karakayalı
Kosekoy, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Comparison of 24 Versus 46-Hour 5-FU Infusion Durations in the Perioperative FLOT Therapy for Gastric Cancer.
Journal: Medicina (Kaunas, Lithuania)
Published: May 26, 2026
First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.
Journal: Medicina (Kaunas, Lithuania)
Published: April 15, 2026
Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study.
Journal: Medicina (Kaunas, Lithuania)
Published: March 22, 2026
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.
Journal: Scientific reports
Published: February 20, 2026
Impact of renin-angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non-small cell lung cancer.
Journal: Expert review of anticancer therapy
Published: January 09, 2026
The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer.
Journal: Discover oncology
Published: November 22, 2025
Prognostic Significance of C-PLAN Index in Patients Treated with Immunotherapy for Non-Small-Cell Lung Cancer.
Journal: Journal of clinical medicine
Published: November 17, 2025
Survival Outcomes and Recurrence Patterns of Early-Stage HER2-Positive Breast Cancer Patients on Adjuvant T-DM1 Treatment: Turkish Oncology Group (TOG) Study.
Journal: Clinical breast cancer
Published: September 07, 2025
HALP-H Index as a Prognostic Biomarker for Predicting Pathological Complete Response in Early-Stage HER2-Positive Breast Cancer-A Multicenter Retrospective Cohort Study.
Journal: Journal of clinical medicine
Published: May 14, 2025
Last Updated: 09/26/2026